Drug metabolism polymorphisms as modulators of cancer susceptibility.
about
MRI visible drug eluting magnetic microspheres for transcatheter intra-arterial delivery to liver tumors.Regulation of cytochrome P450 (CYP) genes by nuclear receptors.NAT2 polymorphism in Omani gastric cancer patients-risk predisposition and clinicopathological associationsSulforaphane and alpha-lipoic acid upregulate the expression of the pi class of glutathione S-transferase through c-jun and Nrf2 activation.Usefulness of genetic susceptibility and biomarkers for evaluation of environmental health risk.Genetic polymorphisms and metabolism of endocrine disruptors in cancer susceptibility.Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer.DNA polymorphisms as modulators of genotoxicity and cancer.Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction.Modern cancer epidemiological research: genetic polymorphisms and environment.Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population.Association of CYP1A1, GSTM1 and GSTT1 gene polymorphisms with risk of non-small cell lung cancer in Andhra Pradesh region of South India.Genetic polymorphisms of human cytosol glutathione S-transferases and prostate cancer.The influence of genetic polymorphisms on population variability in six xenobiotic-metabolizing enzymes.Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): Population distribution of CYP2D6 activity.Genetic Polymorphism in Glutathione Transferases (GST): Population distribution of GSTM1, T1, and P1 conjugating activity.Amonafide: a future in treatment of resistant and secondary acute myeloid leukemia?Glutathione s-transferase gene polymorphism and ischemic cerebrovascular disease.Synthesis and evaluation of novel amonafide-polyamine conjugates as anticancer agents.Role of GST and NAT2 polymorphisms in thyroid cancer.Association of glutathione S-transferase (GSTM1 and GSTT1) genes with chronic myeloid leukemia.Association of glutathione S-transferase M1, T1, and P1 polymorphisms with renal cell carcinoma: evidence from 11 studies.Exposure to pesticides and heterozygote genotype of GSTP1-Alw26I are associated to Parkinson's disease.N-acetyltransferase 2 status and gastric cancer risk: a meta-analysis.Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes in a Brazilian population.Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia.Association between CYP2E1 genetic polymorphisms and urinary cancer risk: a meta-analysis.Association of GSTT1 gene polymorphisms with the risk of prostate cancer: an updating meta-analysis
P2860
Q30624761-E9BA1651-59BF-4553-A770-DDF5224EC49CQ33882753-2CADD373-89D5-4B9F-B6D0-07F220F5D664Q34100038-17B7D526-8612-4AC5-862E-5DA8408A9FD6Q34104422-A2DA0251-462A-4056-B8B6-F14DB9D662E7Q34228681-E203A837-3500-44A1-BC70-16418CB336C5Q34582043-4979D3D7-2ABA-46E1-9356-5066511210C2Q34704529-94F26666-5ABC-4274-9E95-F16A0CE49AD7Q34835526-A6241755-0E2E-46E8-986E-9920FFD2196FQ35443937-27E28406-22FC-42ED-816B-6B976F1E231AQ36183829-5C0769A4-F6EF-4826-8B18-F0479A5D5457Q36372873-E929466B-E082-414C-AD71-BC140C0C5868Q36811121-465A1F22-2446-42C6-BA1F-ED62F386C388Q37043511-27881AAA-7211-4B2B-A821-2A7FF2A81087Q37698404-24EA79FE-783F-4B13-8677-8D8A76A59B73Q37698407-0039145B-7094-45F8-A9D1-2250BABF6891Q37698411-6A067232-EFA5-4F1A-8194-AC7E758388EFQ37978341-72C21914-D4D0-4FB0-807E-2535888B7730Q38512115-3D699533-B2B3-4CB3-B7B2-F68B5F66C135Q38739564-431DEF85-612E-496C-9FDB-8334A46DBACEQ39871080-FC5DF99C-0365-4401-82DE-BC99B5119F0BQ40186434-DECFD1EA-C584-41A7-A33A-586B93ADAE31Q44118817-E2E43986-5556-433D-BF76-36A71D57D54FQ44895284-2F96B68A-68F5-414E-981E-EE02F0AB848BQ45399927-6DFC1778-0C14-4BA4-9442-F1CD35ACEB30Q46069803-F266CC3E-759F-48BB-9F28-4217AEF5B22EQ46249991-7C088EB7-9D94-41F0-A924-328568F98824Q47135882-93BABF82-CFFC-4107-97B3-8049BB460517Q56529319-D9F6A1D4-D78C-48EE-BD16-3BDE242190DD
P2860
Drug metabolism polymorphisms as modulators of cancer susceptibility.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Drug metabolism polymorphisms as modulators of cancer susceptibility.
@ast
Drug metabolism polymorphisms as modulators of cancer susceptibility.
@en
type
label
Drug metabolism polymorphisms as modulators of cancer susceptibility.
@ast
Drug metabolism polymorphisms as modulators of cancer susceptibility.
@en
prefLabel
Drug metabolism polymorphisms as modulators of cancer susceptibility.
@ast
Drug metabolism polymorphisms as modulators of cancer susceptibility.
@en
P2093
P1433
P1476
Drug metabolism polymorphisms as modulators of cancer susceptibility
@en
P2093
D Malacarne
M Taningher
P304
P356
10.1016/S1383-5742(99)00005-8
P407
P577
1999-05-01T00:00:00Z